Most cited papers from Universidad de La Frontera

The most cited paper from Universidad de La Frontera is "Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial" (Hertzel C. Gerstein et al., 2019), with 3,173 citations. Next come "First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial" (3,110) and "Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease" (2,456).

Showing 50 of 60 papers. Every paper with more than 453 citations is listed.

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.